Bal Pharma Limited (NSE:BALPHARMA)
71.87
-1.47 (-2.00%)
At close: Dec 26, 2025
Bal Pharma Revenue
Bal Pharma had revenue of 740.25M INR in the quarter ending September 30, 2025, with 0.45% growth. This brings the company's revenue in the last twelve months to 2.95B, down -9.07% year-over-year. In the fiscal year ending March 31, 2025, Bal Pharma had annual revenue of 3.03B, down -10.65%.
Revenue (ttm)
2.95B
Revenue Growth
-9.07%
P/S Ratio
0.39
Revenue / Employee
2.99M
Employees
986
Market Cap
1.15B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 3.03B | -361.36M | -10.65% |
| Mar 31, 2024 | 3.39B | 350.03M | 11.51% |
| Mar 31, 2023 | 3.04B | 230.02M | 8.18% |
| Mar 31, 2022 | 2.81B | 306.86M | 12.25% |
| Mar 31, 2021 | 2.51B | 794.34M | 46.43% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 549.64B |
| Aurobindo Pharma | 325.14B |
| Cipla | 279.66B |
| Zydus Lifesciences | 244.94B |
| Apollo Hospitals Enterprise | 232.65B |
| Glenmark Pharmaceuticals | 159.97B |
| Alkem Laboratories | 138.90B |
| Mankind Pharma | 135.46B |